MICOT
Micot is a new molecular entity drug developer for peptides, dedicated to the development of innovative drugs, multi- and protein-based innovative biopharmaceuticals, vaccines and biomolecular drug delivery systems and products, and for drug screening and biopharmaceutical research. The technology combines to provide users with Bio-Res-Deliv, a biological macromolecular respiratory drug delivery system, suitable for the treatment of cardiovascular diseases, metabolic diseases, liver diseases and the like.
MICOT
Industry:
Health Care Medical
Founded:
2007-01-01
Address:
Xixian, Heilongjiang, China
Country:
China
Website Url:
http://www.micot.cn
Total Employee:
51+
Status:
Active
Contact:
029-89303986
Email Addresses:
[email protected]
Total Funding:
115 M CNY
Technology used in webpage:
Google Analytics Google Universal Analytics Nginx DigiCert SSL IIS 8 Baidu Analytics Tencent Cloud Tencent Waterproof Wall Tencent Analytics
Similar Organizations
BetterNight
BetterNight is providing telehealth-based sleep solutions.
mfine
Mfine is a health-tech startup developing an AI-powered telemedicine mobile app.
PegBio
PegBio is a Chinese innovative drug developer.
Qiyu Biotech
Qiyu Biotech is an innovative macromolecular drug developer.
Virogin Biotech
Virogin Biotech is an antineoplastic drug developer.
Yaohai Bio
Yaohai Bio is a genetic engineering protein drug developer
ZSPepLib
ZSPepLib is a polypeptide drug developer.
Current Employees Featured
Founder
Investors List
DT Capital Partners
DT Capital Partners investment in Seed Round - Micot
Tasly Holding Group
Tasly Holding Group investment in Seed Round - Micot
Northern Light Venture Capital
Northern Light Venture Capital investment in Seed Round - Micot
More informations about "Micot"
陕西麦科奥特科技有限公司
公司是一家专注于新药研发的创新型医药科技企业，致力于成为双功能和多功能特异性多肽药物研发的全球领军性前沿企业，公司聚焦于心脑血管、代谢性疾病、炎症疼痛相关疾病新药的研发 …See details»
发展历史|陕西麦科奥特科技有限公司-陕西麦科奥特科技有限公司
公司是一家专注于新药研发的创新型医药科技企业，致力于成为双功能和多功能特异性多肽药物研发的全球领军性前沿企业，公司聚焦于心脑血管、代谢性疾病、炎症疼痛相关疾病新药的研发 …See details»
Micot - Crunchbase Company Profile & Funding
Micot is a new molecular entity drug developer for peptides, dedicated to the development of innovative drugs, multi- and protein-based innovative biopharmaceuticals, vaccines and …See details»
Shaanxi Micot Technology Co., Ltd. - Drug pipelines, Patents
Shaanxi Micot Technology Co., Ltd. is a privately-owned enterprise based in China that specializes in researching, developing, and producing pharmaceutical products for the …See details»
Micot Technology Ltd. - VentureRadar
Jun 3, 2024 · Website: http://www.micot.cn/ Shaanxi Micot Technology Co., Ltd. is a high-tech company specializing in preclinical and clinical research of new drugs.See details»
陕西麦科奥特科技有限公司 | LinkedIn
麦科奥特科技有限公司是一家面向世界的制药公司，我们致力于成为双功能和多功能特异性多肽新分子实体药物研发，成为多肽新药细分领域No.1，心血管创新药物No.1。...See details»
Micot Company Profile - Office Locations, Competitors, Revenue
See insights on Micot including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Micot Technology - Products, Competitors, Financials, Employees ...
Micot Technology is dedicated to addressing unmet clinical needs and safeguarding human health through scientific and technological innovation. It was founded in 2007 and is based in Xi'an, …See details»
Micot Technology - Overview, News & Similar companies
Micot Technology contact info: Phone number: +86 2989303986 Website: www.micot.cn What does Micot Technology do? Micot Technology Co Ltd is a company that operates in the …See details»
Shaanxi Micot Technology Co., Ltd. (陕西麦科奥特科技有限公司)
NO1~注射用MT1009MT1009，是由陕西麦科奥特科技有限公司开发的双特异性多肽药物，为全球首个作用在成骨细胞及骨髓间充质干细胞的预防及治疗骨质疏松治疗药物。 相比特立帕肽和 …See details»
Innovative Drug Developer Micot Nets Over CNY 100 Mn in Series C
Feb 10, 2023 · Micot (Chinese: 麦科奥特) announced that it had raised an over CNY 100 million Series C funding round, which was led by Chang An Hui Tong Fund (Chinese: 长安汇通基金) …See details»
十年磨一剑,一朝试锋芒---MICOT七个国家级1类新药共11项IND申 …
Sep 12, 2023 · 公司获得了国家级多肽和蛋白质药物长效缓释研究平台称号，已建立多肽长效缓控释制剂研究实验室及基于双/多功能多肽的大分子生物药平台。 公司已具备开发First-in-class …See details»
MICOT（麦科奥特）完成3.6亿元B轮融资，加速推进双功能多肽药 …
May 21, 2021 · 麦科奥特是面向全球的中外合资创新药物研发公司，拥有业内领先的双特异性多肽药物技术平台及国家级肽类药物制剂平台，已建立起包括20个1.1类新药品种的产品管线，覆 …See details»
Michael Chen - Micot Technology Ltd. | ChinaBio® Partnering …
R&D staged pipelines, such as pain, pruritus, Dry-AMD and other indications therapeutics, enhance the unique field of indication strategy of Micot, and also illustrate the ability of Micot …See details»
麦科奥特第三届战略研讨峰会顺利召开 - micot.cn
2021年10月20日至22日，麦科奥特第三届战略研讨会在苏州世豪国际大酒店顺利召开。公司创始人及董事长王冰博士、研发高级副总裁余惟平先生、苏州子公司总经理巨杭生先生及各职能部 …See details»
【首发】MICOT (麦科奥特)完成超亿元C轮融资，加速推进双功能 …
Feb 10, 2023 · 麦科奥特是一家专注于新药研发的创新型医药科技企业，致力于成为双功能和多功能特异性多肽药物研发的全球领军性前沿企业，聚焦于心脑血管、代谢性疾病、炎症疼痛相关 …See details»
【首发】MICOT (麦科奥特)完成3.6亿元B轮融资， 加速推进双功能 …
May 21, 2021 · 麦科奥特是面向全球的中外合资创新药物研发公司，拥有业内领先的双特异性多肽药物技术平台及国家级肽类药物制剂平台，已建立起包括20个1.1类新药品种的产品管线，覆 …See details»
陕西麦科奥特科技有限公司 - micot.cn
Jul 12, 2024 · 公司是一家专注于新药研发的创新型医药科技企业，致力于成为双功能和多功能特异性多肽药物研发的全球领军性前沿企业，公司聚焦于心脑血管、代谢性疾病、炎症疼痛相关疾 …See details»
Micot targets anticoagulant breakthrough with $15M round
Feb 14, 2023 · Shaanxi Micot Technology Co. Ltd.’s MT-1011 is a synthetic water-soluble small-molecule anticoagulant antagonist. After a single intravenous dose, it can bind directly to other …See details»
MICOT（麦科奥特）全球首创新药MT1013大样本量 ... - Pharmcube
Jun 3, 2024 · 麦科奥特是一家面向世界的制药公司，聚焦心脑血管、代谢、内分泌、疼痛领域，为全球患者开发具有临床价值的药物。 每年，麦科奥特都会深度洞察行业趋势，审视市场变 …See details»